Update on imaging and anti-VEGF therapy for diabetic retinopathy

• Published in: Kerala journal of ophthalmology Vol. 34; no. 2; pp. 98 - 103
• Main Authors: Sen, Sagnik, Sivaprasad, Sobha
• Format: Journal Article
• Language: English
• Published: Medknow Publications and Media Pvt. Ltd 01-05-2022; Wolters Kluwer Medknow Publications
• Subjects: anti-vegf; Diabetic retinopathy; Diagnosis; Diagnostic imaging; Drug therapy; Health aspects; Methods; Monoclonal antibodies; Vascular endothelial growth factor; widefield retinal imaging; India
• DOI: 10.4103/kjo.kjo_65_22
• EISSN: 0976-6677

The classification of diabetic retinopathy has been based on 7-field photographs. With advances in retinal imaging, there is an unmet need to reclassify this condition as new predictive factors have been identified in the peripheral retina. In addition, we have transitioned from an era of laser treatment for vision-threatening complications to robust evidence that anti-VEGF therapy can modulate the diabetic retinopathy scores. In this review, the literature on both retinal imaging and role of anti-VEGF on diabetic retinopathy highlights both the merits and shortcomings of available evidence in this area.